Skip to Content
Merck
  • Selective inhibition of aromatase by a dihydroisocoumarin from Xyris pterygoblephara.

Selective inhibition of aromatase by a dihydroisocoumarin from Xyris pterygoblephara.

Journal of natural products (2008-05-09)
Denise C Endringer, Keller G Guimarães, Tamara P Kondratyuk, John M Pezzuto, Fernão C Braga
ABSTRACT

Aromatase is a well-established target for the chemoprevention of breast cancer. The dihydroisocoumarin (3 R,4 R)-(-)-6-methoxy-1-oxo-3-pentyl-3,4-dihydro-1 H-isochromen-4-yl acetate (1) (IC 50 = 1.6 +/- 0.1 microM), isolated from aerial parts of Xyris pterygoblephara, showed aromatase inhibitory activity. The specificity of 1 was evaluated by inhibition assays with cytochrome P450 enzymes. CYP1A1 was inhibited modestly (IC 50 = 38.0 +/- 2.0 microM), while CYP2C8 and CYP3A4 enzymes were not affected. Dihydroisocoumarin 1 showed weak antiproliferative activity against MCF-7 (IC 50 = 66.9 +/- 2.3 microM) and LNCaP (IC 50 = 57.5 +/- 2.0 microM) cells and was inactive against LU-1 and HepG2 cells in culture. These results demonstrate the potential of dihydroisocoumarin 1 to serve as a selective aromatase inhibitor.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Naringin, ≥90% (HPLC), from citrus fruit